Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/05/1998CA2263985A1 Stable radioiodine conjugates and methods for their synthesis
03/05/1998CA2263978A1 Enhanced stimulation of erythropoiesis
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998CA2263935A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263826A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998CA2263824A1 Cd95 regulatory gene sequences and transcription factors
03/05/1998CA2263802A1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery
03/05/1998CA2263791A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998CA2263685A1 Use of glp-1 or analogs in treatment of myocardial infarction
03/05/1998CA2262453A1 Modulators of .beta.-amyloid peptide aggregation comprising d-amino acids
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/05/1998CA2235867A1 Hematopoietic stem cell growth factor (scgf)
03/05/1998CA2194256A1 Ikaros: a t cell pathway regulatory gene
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826696A1 Use of bi-and trispecific antibodies for inducing tumor immunity
03/04/1998EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies
03/04/1998EP0826375A2 Use of complex lipids as stabilizing additives for pharmaceutical preparations of digestive enzymes
03/04/1998EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
03/04/1998EP0826373A1 Preventive for postoperative astigmatism
03/04/1998EP0826064A1 Low oxygen affinity mutant hemoglobin
03/04/1998EP0826063A1 Single-vial formulations of dna/lipid complexes
03/04/1998EP0826058A2 Chimeric mcp and daf proteins with cell surface localizing domain
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826053A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE
03/04/1998EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
03/04/1998EP0826049A1 Human interferon tau compositions and methods of use
03/04/1998EP0826048A1 Pancreas-derived serpin
03/04/1998EP0826046A1 Autoantigen which can be used to detect a tendency to thrombosis
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826044A1 Bmp-15 compositions
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826040A1 CANDIDA HEAT SHOCK PROTEIN, cDNA AND USES THEREOF
03/04/1998EP0826033A1 Ataxia-telangiectasia gene
03/04/1998EP0826031A1 Ataxia-telangiectasia gene and its genomic organization
03/04/1998EP0826006A1 Transeptithelial transport of molecular species
03/04/1998EP0826005A1 Avian, vitellin antibodies directed against hiv antigens
03/04/1998EP0826004A1 Storage stable hemoglobin solutions
03/04/1998EP0826003A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
03/04/1998EP0826002A2 Biologically active peptide fragments of ob protein
03/04/1998EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
03/04/1998EP0825999A1 Amines exhibiting analgesic action, their preparation and use
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825885A1 Pulmonary delivery of aerosolized medicaments
03/04/1998EP0825872A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
03/04/1998EP0825871A1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
03/04/1998EP0825870A1 Modulation of cytokine patterns of human autoreactive t-cell clones
03/04/1998EP0825868A1 Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
03/04/1998EP0825867A1 N,o-carboxymethylchitosan for prevention of surgical adhesions
03/04/1998EP0825863A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
03/04/1998EP0662129B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/04/1998EP0656121B1 Method for diagnosing and monitoring sepsis
03/04/1998EP0644948B1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/04/1998EP0625988A4 Allosteric modulators of the nmda receptor.
03/04/1998EP0617614B1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175262A Novel receptor
03/04/1998CN1175261A Spray dried erythropoietin
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
03/04/1998CN1175259A Low molecular weight bicyclic thrombin inhibitors
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/04/1998CN1175213A Irrigation solution and method for inhibition of pain, inflammation
03/04/1998CN1174845A Method for synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
03/04/1998CN1174743A Application of composite fat used as stabilizing additive in medicine of digestive enzyme mixture
03/04/1998CN1174742A Complex cow's milk gamma globulin and the making method thereof
03/03/1998US5723616 Process for the preparation of a growth hormone secretagogue
03/03/1998US5723602 Angiotensin converting enzyme and endopeptidase inhibitors, cardiovascular disorders
03/03/1998US5723585 Method of purifying cardiac hypertrophy factor
03/03/1998US5723584 Polypeptides and dna for genetic engineering
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723582 Immunology and autoimmune diseases
03/03/1998US5723581 Murine and human box-dependent myc-interacting protein (Bin1)
03/03/1998US5723578 Peptide analogs of bombesin
03/03/1998US5723577 Analogs of parathyroid hormone
03/03/1998US5723576 Polypeptides for enzyme inhibitors and hirundin
03/03/1998US5723575 Process for the preparation of backbone cyclic peptides
03/03/1998US5723504 Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers
03/03/1998US5723503 Biological treatment for rheumatoid arthritis
03/03/1998US5723490 THF-containing sulfonamide inhibitors of aspartyl protease
03/03/1998US5723482 Active compounds and cosmetic and dermatological formulations
03/03/1998US5723457 Acylmercaptoalkanoylamino and mercaptoalkanoylamino benzazepines
03/03/1998US5723446 Medium chain triglycerides, omega-3 and omega-6 fatty acids
03/03/1998US5723444 Enzyme inhibitors and anticoagulants
03/03/1998US5723442 Peptide derivatives
03/03/1998US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3
03/03/1998US5723439 Pharmaceutical aerosol composition and application thereof for treatment and prophylaxis of viral diseases
03/03/1998US5723438 Administering the soluble antiviral domain of the ldl receptor protein of seq id no:2 or a salt, derivative or mutant thereof
03/03/1998US5723437 Glycoproteins and cell surfaces and scavenger receptors
03/03/1998US5723436 Immunosuppressants
03/03/1998US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
03/03/1998US5723335 Immune stimulation by phosphorothioate oligonucleotide analogs
03/03/1998US5723333 Vectors of oncogenes, promoters, transcription
03/03/1998US5723327 Hydrolyzes oligo- and polysaccharides with trehalose end unit; culturing sulfobus; foods, cosmetics, drugs
03/03/1998US5723325 Indolyl-3-alkane alpha-hydroxylase compositions from pseudomonas XA
03/03/1998US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
03/03/1998US5723314 Antigens and antibodies and peptides